TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy.

K Blackwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.